Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30096713 | 0.85 | KDM4E (0.72) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL9755022 | 0.84 | KDM4E (0.97) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL3614618 | 0.83 | KDM4E (1.00) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL20152243 | 0.83 | KDM4E (1.00) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL18896226 | 0.83 | KDM4E (1.00) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL3924178 | 0.83 | KDM4E (1.00) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL6359528 | 0.83 | KDM4E (0.88) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL28223294 | 0.83 | KDM4E (0.68) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL26922312 | 0.83 | KDM4E (0.68) | KDM4EKMT2AMEN1POLBLMNA | |
| SCHEMBL5656679 | 0.82 | KDM4E (0.72) | KDM4EKMT2AMEN1POLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6503898-B1 | Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-01-07 | — | — | US | disclosed |